Literature DB >> 8042032

The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis.

E A Perez1, D R Gandara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8042032

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis.

Authors:  E A Perez; R M Navari; H G Kaplan; R J Gralla; S M Grunberg; R H Palmer; D Fitts
Journal:  Support Care Cancer       Date:  1997-01       Impact factor: 3.603

Review 2.  A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis.

Authors:  E A Perez
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 3.  Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.

Authors:  G L Plosker; P Benfield
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 4.  Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities.

Authors:  Sara SantaCruz-Calvo; Leena Bharath; Gabriella Pugh; Lucia SantaCruz-Calvo; Raji Rajesh Lenin; Jenny Lutshumba; Rui Liu; Adam D Bachstetter; Beibei Zhu; Barbara S Nikolajczyk
Journal:  Nat Rev Endocrinol       Date:  2021-10-26       Impact factor: 43.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.